Osteoporosis Drugs
October 14, 2020
Save Our Bones Bulletin: Bisphosphonates Shown To Cause Inflexible Bones; Vitamin D Deficiency Linked To Low Muscle Function; Exercise Can Prevent Falls
The studies we review in this month’s Save Our Bones Bulletin focus on our ability to keep improving our health as we age. Wherever you are in your bone-building journey, … Continue Reading →
September 21, 2020
Could Following Doctor’s Orders Land You In The Hospital?
A new report from medical think-tank the Lown Institute has revealed shocking information about the harm that prescription drugs cause to older Americans following their doctor’s orders. Not only are … Continue Reading →
August 31, 2020
Save Our Bones Bulletin: Beware Of The New Osteoporosis Drugs On The Horizon
In this Bulletin, we’re covering research racing to develop new drug treatments for osteoporosis. The discoveries surrounding these endeavors are nonetheless fascinating and contain new insights about how complex and … Continue Reading →
July 15, 2020
Alert! Confirmed Serious Health Risk Of Recently-Approved Evenity
A meta-analysis study just published in the journal Science Translational Medicine points to cardiovascular risks caused by a recently approved and widely prescribed osteoporosis drug. A meta-analysis covers several studies … Continue Reading →
June 3, 2020
Fewer People Using Drugs To Treat Osteoporosis
As Savers surely know, May was National Osteoporosis Awareness and Prevention Month. Fortunately, we have evidence that awareness is indeed growing, as more and more people are learning about their … Continue Reading →
February 10, 2020
Save Our Bones Bulletin: Rising Atypical Fracture Risk From Bisphosphonates, Soft Drinks Proven To Cause Fractures, Social Stress Linked To Low Bone Density
This month we’ll look at three different causes of increased fracture risk, based on recently published studies. Each one contains actionable information that you can use to maintain bone quality … Continue Reading →
October 28, 2019
Save Our Bones Bulletin: Positive Bisphosphonate Study Disproven, New Osteoporosis Drug On The Horizon, Major Changes To FDA Osteoporosis Drug Testing Guidelines
This month’s Save Our Bones Bulletin tackles news about osteoporosis drugs and the pharmaceutical industry. We’ll examine newly published studies to ensure that you have the most accurate and up-to-date … Continue Reading →
August 1, 2019
Save Our Bones Bulletin: Study Reveals Most Drugs Are Ineffective, NSAIDs Increase Risk Of Heart Attack After Just One Week, European Regulatory Body Rejects Evenity
Today’s Bulletin provides valuable information and breaking news about Big Pharma and the harmful side effects of the drugs they produce. We’ll look at a German study that examined the … Continue Reading →
July 2, 2019
Fluoride, Bone Health, And How To Detox From It
Fluoride is all around us: in tap water, toothpaste, cookware, and pesticides. Many people don’t realize just how much fluoride we are exposed to every day, and even fewer are … Continue Reading →
June 5, 2019
Evenity (Romosozumab): Everything You Need To Know About This New Osteoporosis Drug
The Food and Drug Administration (FDA) has recently approved a new injectable osteoporosis drug, Evenity (romosozumab), developed by drug-maker Amgen. The same drug was rejected by the FDA in 2017 … Continue Reading →
